Compound 136
Identifiers
- Canonical SMILES:
CC(C)c1ccccc1Sc1ccc([C@@H]2C[C@H]2C(=O)NCCCC(O)=O)c(Cl)c1Cl
- IUPAC name:
4-[[2-[2,3-dichloro-4-(2-propan-2-ylphenyl)sulfanylphenyl]cyclopropanecarbonyl]amino]butanoic acid
- InChi:
InChI=1S/C23H25Cl2NO3S/c1-13(2)14-6-3-4-7-18(14)30-19-10-9-15(21(24)22(19)25)16-12-17(16)23(29)26-11-5-8-20(27)28/h3-4,6-7,9-10,13,16-17H,5,8,11-12H2,1-2H3,(H,26,29)(H,27,28)/t16-,17+/m0/s1
- InChiKey:
OHELAVHWEMILBF-DLBZAZTESA-N
External links
91253032 |
19174436 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 8.15 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 465.09 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 6.04 | |||
TPSA | 66.40 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5304 | Tedatioxetine | DB12641 | |
0.5210 | Mitiglinide | DB01252 | |
0.5042 | 6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid | DB03471 | |
0.4844 | Metixene | DB00340 | |
0.4776 | WRR-99 | DB03573 | |
0.4776 | WRR-112 | DB03691 | |
0.4692 | Kelatorphan | DB08040 | |
0.4654 | N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide | DB08429 | |
0.4621 | Enalaprilat | DB09477 | |
0.4615 | NS-2359 | DB05805 | |
0.4583 | AMG-232 | DB15299 | |
0.4552 | GSK-424887 | DB12219 | |
0.4546 | Amitifadine | DB05964 | |
0.4485 | Lisinopril | DB00722 | |
0.4478 | Tesofensine | DB06156 |